Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07445191) titled 'Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).
Primary Sponsor: Cairo University
Condition:
TMJ Pain
Intervention:
Drug: Saline
Drug: Triamcinolone with lidocaine
Recruitment Status: Not recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: March 1, 2026
Target Sample Size: 30
To know more, visit https:/...